Diagnosis and Treatment of Allergic Conjunctivitis
For allergic conjunctivitis, start with dual-action topical agents (olopatadine, ketotifen, epinastine, or azelastine) as first-line treatment, which provide both immediate relief and ongoing protection through combined antihistamine and mast cell stabilizer properties. 1
Clinical Diagnosis
Key diagnostic features:
- Bilateral eye involvement with itching as the predominant symptom 2
- Conjunctival injection and chemosis with tearing 2
- Often accompanies allergic rhinitis (allergic rhinoconjunctivitis) 2
- More than 75% of seasonal allergic rhinitis patients report ocular symptoms 2
Important diagnostic distinctions:
- Seasonal allergic conjunctivitis: Associated with pollen exposure (trees, grasses, weeds) 2
- Perennial allergic conjunctivitis: Year-round symptoms from indoor allergens like dust mites 2
- Vision-threatening forms requiring ophthalmology referral:
Diagnostic testing when indicated:
- Allergy skin testing is highly sensitive and specific for aeroallergens 2
- Positive skin prick test identifies allergens in 82% of ocular allergy patients 2
- Diagnosis can be made clinically even with negative IgE testing if history is compelling 2
Treatment Algorithm
Step 1: Non-Pharmacological Measures (All Patients)
- Cold compresses and saline irrigation or artificial tears for mild symptoms 2, 1
- Refrigerated preservative-free artificial tears to dilute allergens and inflammatory mediators 1, 3
- Allergen avoidance: hypoallergenic bedding, frequent clothes washing, showering before bedtime 1
- Wear sunglasses as physical barrier against airborne allergens 1
- Avoid eye rubbing, which can lead to keratoconus in atopic patients 1
Step 2: First-Line Pharmacological Treatment
Dual-action topical agents (antihistamine + mast cell stabilizer):
- Olopatadine, ketotifen, epinastine, or azelastine 2, 1, 3
- Onset of action within 30 minutes, suitable for both acute and chronic treatment 2, 3
- Can be stored in refrigerator for additional cooling relief 1
- No maximum treatment duration specified, unlike corticosteroids 3
- Superior to oral antihistamines, which may worsen dry eye syndrome and impair tear film 2, 1, 3
Alternative first-line options:
- Topical antihistamines alone (emedastine, levocabastine) for acute relief 2, 3
- Combination antihistamine/vasoconstrictor (pheniramine, antazoline) works better than either agent alone 2
Step 3: Second-Line Treatment (If Inadequate Response)
Mast cell stabilizers for prophylaxis:
- Cromolyn, lodoxamide, nedocromil, or pemirolast 2, 3
- Slow onset requiring several days for optimal effect 2, 3
- Better for prophylactic or longer-term treatment than acute relief 2, 3
Topical NSAIDs:
Step 4: Third-Line Treatment (Severe Symptoms or Acute Exacerbations)
Topical corticosteroids - use with extreme caution:
- Loteprednol etabonate (Alrex) is preferred due to reduced IOP risk 2, 4
- Strictly limit to 1-2 weeks maximum 1, 3
- Requires baseline and periodic IOP measurement plus pupillary dilation to evaluate for glaucoma and cataract 1
- Vision-threatening risks: cataract formation, elevated IOP, secondary infections 2, 1, 3
- Loteprednol showed 1% IOP elevation rate vs. 6% with prednisolone acetate 4
Step 5: Refractory Cases
For severe cases unresponsive to above treatments:
- Topical cyclosporine 0.05% or tacrolimus 1, 3
- Cyclosporine 0.1% is FDA-approved for vernal keratoconjunctivitis in children and adults 1
- May allow reduced corticosteroid use 1
- For eyelid involvement (ages 2+): pimecrolimus cream 1% or tacrolimus ointment 0.03% 1
Systemic options for severe atopic/vernal keratoconjunctivitis:
- Allergen-specific immunotherapy (subcutaneous or sublingual) 1
- Rarely: montelukast, interferons, oral cyclosporine or tacrolimus 1
Systemic Treatments for Associated Rhinitis
When allergic conjunctivitis accompanies rhinitis:
- Oral antihistamines, intranasal antihistamines, oral anti-leukotriene agents, intranasal corticosteroids, and allergen immunotherapy all relieve ocular symptoms 2
- Intranasal corticosteroids, oral antihistamines, and intranasal antihistamines have similar effectiveness for eye symptoms 2
- Fluticasone furoate nasal spray significantly reduces ocular symptoms in seasonal allergic rhinitis 2
Critical Pitfalls to Avoid
- Never use punctal plugs in allergic conjunctivitis - they prevent flushing of allergens and inflammatory mediators 1, 3
- Avoid prolonged vasoconstrictor use (>10 days) - causes rebound hyperemia (conjunctivitis medicamentosa) 2, 1, 3
- Avoid oral antihistamines as primary ocular treatment - they worsen dry eye 2, 1, 3
- Never use topical antibiotics - they induce toxicity and are not indicated 1
- Monitor for keratoconus in atopic patients who rub their eyes 1
When to Refer to Ophthalmology
- Suspected vernal or atopic keratoconjunctivitis 2
- Any corneal involvement or vision changes 2
- Disease uncontrolled with topical medications and oral antihistamines 1
- Need for corticosteroid therapy beyond 1-2 weeks 1
- If symptoms fail to improve within 48 hours on dual-action drops, add brief loteprednol course with ophthalmology monitoring 1